Nonalcoholic Fatty Liver Disease among Patients with Hypothalamic and Pituitary Dysfunction

Hepatology

Volumn 39, Issue 4, 2004, Pages 909-914

  Adams, Leon A ^a   Feldstein, Ariel ^a   Lindor, Keith D ^a   Angulo, Paul ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CRANIOPHARYNGIOMA; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS DISEASE; LIVER TRANSPLANTATION; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOPITUITARISM; HYPOTHALAMIC DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 1842480297     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20140     Document Type: Article

References (32)

1. Brobeck JR. Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 1946;26:541-559.
2. Lustig R. Hypothalamic obesity: the sixth cranial endocrinopathy. Endocrinologist 2002;12:210-217.
3. Roth C, Wilken B, Hanefeld F, Schroter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998;138: 89-91.
4. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001; 21:89-104.
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
6. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. HEPATOLOGY 2002;35:367-372.
7. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002;35:373-379.
8. Mersebach H, Svendsen OL, Holst JJ, Astrup A, Feldt-Rasmussen U. Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals. Clin Endocrinol (Oxf) 2003;58:65-71.
9. Altuntas B, Ozcakar B, Bideci A, Cinaz P. Cirrhotic outcome in patients with craniopharyngioma. J Pediatr Endocrinol Metab 2002;15:1057-1058.
10. Basenau D, Stehphani U, Fischer G. Development of complete liver cirrhosis in hyperphagia-induced fatty liver [in German]. Klin Padiatr 1994; 206:62-64.
11. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
12. Zelman S. The liver in obesity. Arch Intern Med 1952;90:141-156.
13. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003;37: 1202-1219.
14. Jeffcoate W. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Saf 2002;25:199-212.
15. Holt RI, Simpson HL, Sonksen PH. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 2003; 20:3-15.
16. Ichikawa T, Hamasaki K, Ishikawa H, Ejima E, Eguchi K, Nakao K. Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency. Gut 2003;52:914.
17. Lonardo A, Loria P, Leonardi F, Ganazzi D, Carulli N. Growth hormone plasma levels in nonalcoholic fatty liver disease. Am J Gastroenterol 2002; 97:1071-1072.
18. Langendonk JG, Meinders AE, Burggraaf J, Frolich M, Roelen CA, Schoemaker RC, Cohen AF, et al. Influence of obesity and body fat distribution on growth hormone kinetics in humans. Am J Physiol 1999;277:E824-E829.
19. Beshyah SA, Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol (Oxf) 1999;50:1-15.
20. Ozbey N, Algun E, Turgut AS, Orhan Y, Sencer E, Molvalilar S. Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency. Int J Obes Relat Metab Disord 2000;24:619-626.
21. Page RC, Levy J, Turner RC. Obesity associated insulin resistance occurs in hypopituitary subjects. Diabet Med 1994;11:862-865.
22. Hennessey JV, Jackson IM. Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly. Baillieres Clin Endocrinol Metab 1995;9:271-314.
23. Svensson J, Bengtsson BA. Growth hormone replacement therapy and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1453-4.
24. al-Shoumer KA, Anyaoku V, Richmond W, Johnston DG. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 1997;47:153-159.
25. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 2002;16:623-637.
26. Pinkney J, Wilding J, Williams G, MacFarlane I. Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 2002;3:27-34.
27. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
28. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003;11:525-531.
29. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, Lang T, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122:1399-1410.
30. Saxena NK, Ikeda K, Rockey DC, Friedman SST, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. HEPATOLOGY 2002;35:762-771.
31. Alba LM, Petrovic LM, Lindor KD, Talwalkar JA, Angulo P. Leptin is an independent marker of liver fibrosis in humans with nonalcoholic fatty liver disease [abstract]. HEPATOLOGY 2002;36:296A.
32. Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastroenterol 2002;97:1074-1075.